Literature DB >> 20333418

Effects of raloxifene treatment on the structural geometry of the proximal femur in Japanese women with osteoporosis.

Junichi Takada1, Takami Miki, Yasuo Imanishi, Kiyoshi Nakatsuka, Hiroshi Wada, Hiroshi Naka, Takashi Yoshizaki, Kousuke Iba, Thomas J Beck, Toshihiko Yamashita.   

Abstract

The purpose of this study was to clarify the effects of 2-year treatment with raloxifene on the proximal femoral geometry among Japanese patients with osteoporosis by hip structure analysis. One hundred ninety-eight community-dwelling postmenopausal women with osteoporosis were enrolled. The structural variables were areal bone mineral density (BMD), cross-sectional area (CSA), section modulus (index of resistance to bending forces), and buckling ratio (index of cortical instability). BMD, CSA, and section modulus at the narrow neck significantly increased by 1.27, 2.67, and 3.90% at 2 years, respectively. BMD, CSA, and section modulus at the intertrochanter significantly increased by 2.55, 4.49, and 6.60% at study termination, respectively. The buckling ratio at the intertrochanter decreased by 2.36% at 1 year, but differences at 2 years became non-significant. Parameters at the shaft were qualitatively similar to those of the narrow neck and intertrochanter. The percent change of the section modulus was significantly higher than that of BMD at 2 years in all three regions. The percent changes of the section modulus is strongly correlated with the percent changes of BMD and CSA, and negative correlated with the percent changes of buckling ratio in all regions. In conclusion, Japanese osteoporotic women on raloxifene therapy have significant improvements of both BMD and geometry in the proximal femur.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20333418     DOI: 10.1007/s00774-010-0164-5

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  30 in total

1.  Sex differences in geometry of the femoral neck with aging: a structural analysis of bone mineral data.

Authors:  T J Beck; C B Ruff; W W Scott; C C Plato; J D Tobin; C A Quan
Journal:  Calcif Tissue Int       Date:  1992-01       Impact factor: 4.333

2.  Cross-sectional geometry of Pecos Pueblo femora and tibiae--a biomechanical investigation: I. Method and general patterns of variation.

Authors:  C B Ruff; W C Hayes
Journal:  Am J Phys Anthropol       Date:  1983-03       Impact factor: 2.868

3.  Varying contributions of growth and ageing to racial and sex differences in femoral neck structure and strength in old age.

Authors:  Xiao-Fang Wang; Yunbo Duan; Thomas J Beck; Ego Seeman
Journal:  Bone       Date:  2005-06       Impact factor: 4.398

4.  Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy.

Authors:  Somnath Sarkar; Bruce H Mitlak; Mayme Wong; John L Stock; Dennis M Black; Kristine D Harper
Journal:  J Bone Miner Res       Date:  2002-01       Impact factor: 6.741

5.  Effects of teriparatide [rhPTH (1-34)] treatment on structural geometry of the proximal femur in elderly osteoporotic women.

Authors:  Kirsti Uusi-Rasi; Lisa M Semanick; Jose R Zanchetta; Cesar E Bogado; Erik F Eriksen; Masahiko Sato; Thomas J Beck
Journal:  Bone       Date:  2005-06       Impact factor: 4.398

6.  Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators.

Authors:  B Ettinger; D M Black; B H Mitlak; R K Knickerbocker; T Nickelsen; H K Genant; C Christiansen; P D Delmas; J R Zanchetta; J Stakkestad; C C Glüer; K Krueger; F J Cohen; S Eckert; K E Ensrud; L V Avioli; P Lips; S R Cummings
Journal:  JAMA       Date:  1999-08-18       Impact factor: 56.272

7.  Hormone therapy improves femur geometry among ethnically diverse postmenopausal participants in the Women's Health Initiative hormone intervention trials.

Authors:  Zhao Chen; Thomas J Beck; Jane A Cauley; Cora E Lewis; Andrea LaCroix; Tamsen Bassford; Guanglin Wu; Duane Sherrill; Scott Going
Journal:  J Bone Miner Res       Date:  2008-12       Impact factor: 6.741

8.  Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial.

Authors:  P D Delmas; H K Genant; G G Crans; J L Stock; M Wong; E Siris; J D Adachi
Journal:  Bone       Date:  2003-10       Impact factor: 4.398

Review 9.  Diagnosis of osteoporosis and assessment of fracture risk.

Authors:  John A Kanis
Journal:  Lancet       Date:  2002-06-01       Impact factor: 79.321

10.  DXA-based hip structural analysis of once-weekly bisphosphonate-treated postmenopausal women with low bone mass.

Authors:  S L Bonnick; T J Beck; F Cosman; M C Hochberg; H Wang; A E de Papp
Journal:  Osteoporos Int       Date:  2008-10-02       Impact factor: 4.507

View more
  3 in total

1.  The SERM raloxifene improves diaphyseal fracture healing in mice.

Authors:  Alexander S Spiro; Shahram Khadem; Anke Jeschke; Robert Percy Marshall; Pia Pogoda; Anita Ignatius; Michael Amling; Frank Timo Beil
Journal:  J Bone Miner Metab       Date:  2013-04-02       Impact factor: 2.626

2.  Hip structure analysis of bisphosphonate-treated Japanese postmenopausal women with osteoporosis.

Authors:  Junichi Takada; Genichiro Katahira; Kousuke Iba; Takashi Yoshizaki; Toshihiko Yamashita
Journal:  J Bone Miner Metab       Date:  2010-11-30       Impact factor: 2.626

Review 3.  Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia).

Authors:  Saeko Fujiwara; Etsuro Hamaya; Masayo Sato; Peita Graham-Clarke; Jennifer A Flynn; Russel Burge
Journal:  Clin Interv Aging       Date:  2014-11-05       Impact factor: 4.458

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.